Your session is about to expire
← Back to Search
Device
tDCS for Parkinson's Disease
N/A
Waitlist Available
Led By Nathan C Rowland, MD,PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up subjects will undergo baseline ecog recording 5 min before tdcs starts, during tdcs (5 min after stimulation starts) and 5 min after tdcs stimulation ends. measurements will be made similarly during sham stimulation.
Awards & highlights
Study Summary
This trial will study the effects of transcranial direct current stimulation (tDCS) on subjects with movement deficits due to conditions like Parkinson's disease and stroke. The goal is to understand how tDCS works in order to improve this potentially useful therapy.
Who is the study for?
This trial is for adults over 18 who have previously agreed to be contacted about research studies at the Medical University of South Carolina. It's not suitable for pregnant individuals, those with scalp issues, a history of seizures, metal implants in the head/neck area, prior brain surgery or radiotherapy, or past intracranial tumors/infections/malformations.Check my eligibility
What is being tested?
The study tests how transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique, affects motor control in Parkinson's disease and stroke patients. Participants will undergo tDCS with both noninvasive and invasive recording methods to see if it improves movement symptoms.See study design
What are the potential side effects?
Potential side effects from tDCS may include discomfort at the electrode site on the scalp, itching or tingling during stimulation, fatigue, headache or nausea post-treatment. In rare cases, there could be more serious risks like seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ subjects will undergo baseline eeg recording 5 min before tdcs starts, during tdcs (5 min after stimulation starts) and 5 min after tdcs stimulation ends. measurements will be made similarly during sham stimulation.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~subjects will undergo baseline eeg recording 5 min before tdcs starts, during tdcs (5 min after stimulation starts) and 5 min after tdcs stimulation ends. measurements will be made similarly during sham stimulation.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in primary motor cortical (PriMC) beta oscillations during arm flexion in relation to anodal tDCS activation
Change in primary motor cortical (PriMC) beta oscillations during cued arm reaching in relation to anodal tDCS activation
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Stimulation (invasive recording)Experimental Treatment1 Intervention
Patients with Parkinson's disease undergoing surgery for deep brain stimulation will be studied using electrocorticography combined with transcranial direct current stimulation
Group II: Stimulation (noninvasive recording)Active Control1 Intervention
Patients with Parkinson's disease or chronic stroke will be assigned to undergo EEG recording and transcranial direct current stimulation.
Group III: Sham (noninvasive recording)Placebo Group1 Intervention
Patients with Parkinson's disease or chronic stroke will be assigned to undergo EEG recording and sham transcranial direct current stimulation.
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,394,180 Total Patients Enrolled
Nathan C Rowland, MD,PhDPrincipal InvestigatorMedical University of South Carolina
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had surgery inside your skull before.You have had radiation treatment to your brain before.You have a scalp injury or disease.You have had seizures before.You have metal implants in your head or neck.You had a tumor, infection, or abnormal blood vessels in your brain before
Research Study Groups:
This trial has the following groups:- Group 1: Stimulation (invasive recording)
- Group 2: Stimulation (noninvasive recording)
- Group 3: Sham (noninvasive recording)
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who has the necessary qualifications to join this clinical trial?
"To be eligible for this study, a parkinson disease diagnosis and age between 18 to 80 must be fulfilled. Up to eighty participants will be recruited in total."
Answered by AI
Are there any vacancies left for participants in this experiment?
"According to clinicaltrials.gov, this trial is not currently accepting participants; it was initially posted on January 1st 2021 and the last update occurred on March 21st 2022. Nevertheless, there are 512 other trials actively recruiting patients presently."
Answered by AI
Are individuals of senior age being accepted into this clinical exploration?
"This research study is open to individuals between the ages of 18 and 80. For those below or exceeding this age range, there are 27 trials for minors and 509 studies designed for seniors."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger